Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
03/2006
03/30/2006US20060069091 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance
03/30/2006US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/30/2006US20060069077 Receptor-type kinase modulators and methods of use
03/30/2006CA2581175A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
03/29/2006EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
03/29/2006CN1753897A Fused bicyclic nitrogen-containing heterocycles
03/28/2006US7019014 Process for producing anticancer agent LL-D45042
03/28/2006US7019001 Substituted benzothiazole amide derivatives
03/28/2006US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
03/28/2006US7018960 Formed by inter-molecular interaction of one or more keto-enol tautomeric compounds; for mechanical friction sliding members
03/28/2006US7018808 Polyketides and their synthesis and use
03/23/2006WO2006031929A2 Thiazolopyridine kinase inhibitors
03/23/2006WO2006031664A1 Process for isolation of crystalline tacrolimus
03/23/2006WO2006031357A2 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof
03/23/2006WO2006030211A2 Acyclic sulphonamides
03/23/2006US20060063927 Processes for preparing quetiapine and salts thereof
03/23/2006US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/23/2006CA2580127A1 Process for isolation of crystalline tacrolimus
03/23/2006CA2580123A1 Process for isolation of macrolide compounds
03/22/2006EP1636239A1 Indole derivatives with an improved antipsychotic activity
03/22/2006EP1636227A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity
03/22/2006EP1635641A2 Mitotic kinesin inhibitors
03/22/2006EP1140924B1 Piperazine derivatives
03/22/2006CN1751057A Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses
03/22/2006CN1751050A Benzamide derivatives as oxytocin agonists and vasopressin antagonists
03/22/2006CN1751047A Triazole compounds useful in therapy
03/21/2006US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example
03/21/2006US7015219 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators
03/16/2006US20060058778 Novel compounds
03/16/2006US20060058341 Inhibitors of ATP-protein kinase; 7-(3-chloro-4-fluoro-phenylamino)-2-(4-pyrrolidin-1-ylmethyl-phenylamino)-thiazolo[4,5-b]pyridine-6-carbonitrile
03/16/2006US20060058321 Enzyme inhibitors for kinases and antitumor agents with bicyclic or tricyclic compounds with thiophene ring
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060058287 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
03/16/2006US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
03/16/2006US20060057218 N-[1-butyl-4-piperidinylmethyl[3,4-dihydro-2 oxazino[3,2-a indole-10 carboxamide as drugs with Cahpo4 or Ca3/po4/2 fillers or binders for use in treatment of irritable bowel syndrome, urinry incontience or arrhythmias
03/15/2006EP1633788A2 Monoclonal antibodies specific for buprenorphine and metabolites thereof
03/15/2006EP1633758A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
03/15/2006EP1633365A1 Macrocyclic quinazoline derivatives as antiproliferative agents
03/15/2006EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
03/15/2006EP1309593B1 Substituted pyrazoles
03/15/2006CN1747943A Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
03/14/2006US7012144 Bactericides
03/14/2006US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction
03/14/2006CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors
03/14/2006CA2165800C Antiallergic imidazoazepines
03/09/2006WO2006026531A1 Solvent free amorphous rapamycin
03/09/2006WO2006024501A1 Alternative synthesis of renin inhibitors and intermediates thereof
03/09/2006WO2005099754A3 Maytansinoid analogs as antitumor agents
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052400 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease
03/09/2006US20060052380 Novel compounds
03/09/2006US20060052314 Pharmaceutical combination
03/09/2006US20060052247 Novel herbicides
03/09/2006US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
03/09/2006CA2578781A1 Fused tricyclic derivatives for the treatment of psychotic disorders
03/09/2006CA2578245A1 Solvent free amorphous rapamycin
03/09/2006CA2577945A1 Herbicide combinations comprising special ketoenoles
03/08/2006EP1632494A1 Vasopressin v1a antagonists
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1390371B1 Oxazolo-and furopyrimidines and their use in medicaments against tumors
03/08/2006EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
03/08/2006EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
03/07/2006US7009059 In simple, reproducible manner with increased safety for humans and the environment and with good yields
03/07/2006US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
03/07/2006US7008941 Heterocyclic amides and/or isosteres used as antiinflammatory agents or for prophylaxis of nervous system disorders; combinatorial chemistry; substance P antagonists
03/02/2006WO2006021457A2 Pyrimidine derivatives
03/02/2006WO2006021454A2 Pyrimidine derivatives
03/02/2006WO2006021213A2 Vasopressin v1a antagonists
03/02/2006WO2005105810A3 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
03/02/2006US20060047121 Novel process for preparation of clopidogrel bisulfate polymorph - Form I
03/02/2006US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen
03/02/2006DE102004039789A1 Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments
03/02/2006CA2689274A1 Vasopressin via antagonists
03/02/2006CA2688912A1 Vasopressin v1a antagonists
03/02/2006CA2688865A1 Vasopressin v1a antagonists
03/02/2006CA2578122A1 Pyrimidine derivatives
03/02/2006CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
03/02/2006CA2577251A1 Pyrimidine derivatives
03/02/2006CA2575887A1 Rapamycin polymorph ii and uses thereof
03/01/2006EP1628981A2 Bicyclicpyrimidones and their use to treat diseases
03/01/2006EP1628661A2 Modulators of vr1 receptor
03/01/2006EP0944311B1 Method for antagonizing HEREGUlin or its receptor and use for the inhibition of cancer cells
03/01/2006CN1243754C New process for the production of 9-oxa-3,7-diazobicyclic(3.3.1) nonane
03/01/2006CN1243751C Piperidine compounds as anti-allergic medicine
03/01/2006CN1243735C 2-lminopyrrolidine derivatives
02/2006
02/28/2006CA2173116C Ring-expanded nucleosides and nucleotides
02/24/2006CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/23/2006WO2006020082A1 Inhibitors of hcv replication
02/23/2006WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/23/2006WO2006018280A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
02/23/2006WO2005089118A3 Novel bicyclic compounds as modulators of androgen receptor function and method
02/23/2006WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
02/23/2006US20060041129 Enantiomers of selected fused heterocyclics and uses thereof
02/23/2006US20060041128 Selected fused heterocyclics and uses thereof
02/23/2006US20060041123 Antibacterial agents
02/23/2006US20060040975 Fused ring NK1 antagonists
02/23/2006US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors
02/23/2006US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/23/2006US20060040930 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same
02/23/2006US20060040926 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof